Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sensoreal has developed a flexible and affordable microfluidics-based platform for rapid, quantitative point-of-care diagnostics. Their first product measures Troponin I in blood for cardiac event diagnosis. They also offer a semi‑quantitative test kit ("PSP Alert") for detecting PSP toxins in shellfish. The company provides licensing and contract development/manufacturing services to partners seeking to use their technology. No clinical trial results are referenced; products are positioned as commercial diagnostics rather than therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sensoreal.